Etomay, Rosenda G.
HRN: 16-24-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/10/2023
12/16/2023
IV
2.25gm
Q6
Infected Diabetic Foot Right
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes